Physician profile
Jonathan Li
NPI 1376049940
$4,762.68
in general payments reported to CMS, 2019-2025
12 companies · $1,337 in 2025
The $1,337 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $590 · 2023: $2,308 · 2024: $528 · 2025: $1,337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,581 · Food and Beverage: $1,392 · Travel and Lodging: $999 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,581.25 |
| Food and Beverage | $1,392.42 |
| Travel and Lodging | $998.79 |
| Education | $200.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,581.25 | 2023 | |
| Stryker Corporation | $1,116.16 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $669.15 | 2022-2023 | Abre |
| Penumbra, INC. | $497.73 | 2022-2025 | Indigo System, Ruby Coil |
| Inari Medical, INC. | $441.50 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Galvanize Therapeutics, INC | $139.09 | 2023 | Aliya System |
| Sirtex Medical INC | $120.30 | 2022 | |
| Angiodynamics, INC. | $112.07 | 2024 | Alphavac |
| Depuy Synthes Sales INC. | $33.30 | 2025 | Trufill |
| Trisalus Life Sciences, INC. | $29.18 | 2025 | Trinav Infusion System |
| Amgen INC. | $15.98 | 2024 | Repatha |
| Histosonics, INC. | $6.97 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.